Literature DB >> 15943912

Study of alanine-73 and aspartate-9 of HLA-C locus in Saudi psoriasis patients, using sequence-specific primers (PCR-SSP).

Abdullah Abanmi1, Fahad Al Harthi, Rokaiyah Al Agla, Haseeb Ahmad Khan, Mohammad Tariq.   

Abstract

Alanine at residue 73 (Ala-73) and aspartate at residue 9 (Asp-9) are characteristic to both Cw6 and Cw7 alleles of HLA-C gene and have been suggested as possible markers for psoriasis vulgaris (PsV). However, the results from various ethnic groups/populations are contradictory and inconclusive. In this study, an attempt has been made to examine the association between HLA-C (Ala-73 and Asp-9) and susceptibility to PsV among Saudi patients. Genomic DNA was extracted from 25 Saudi PsV patients and 75 control subjects. Polymerase chain reaction (PCR) was performed to amplify HLA-C sequences using earlier reported primers, C133P and C243PR. Sequence-specific primers were used to specifically detect nucleotide coding for Ala-73 and Asp-9 in all the subjects. The results showed significantly higher frequency of Asp-9 (84.0 % versus 61.3 %) in PsV patients as compared to controls (p < 0.05, 2-tailed Fisher's exact test). The frequencies of Ala-73 among PsV patients (92 %) and controls (88 %) did not differ significantly.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15943912     DOI: 10.5483/bmbrep.2005.38.3.350

Source DB:  PubMed          Journal:  J Biochem Mol Biol        ISSN: 1225-8687


  2 in total

1.  Hla-a and hla-B alleles associated in psoriasis patients from mumbai, Western India.

Authors:  Shankarkumar Umapathy; Aruna Pawar; R Mitra; D Khuperkar; J P Devaraj; K Ghosh; U Khopkar
Journal:  Indian J Dermatol       Date:  2011 Sep-Oct       Impact factor: 1.494

2.  Clonal immune responses of Mycobacterium-specific γδ T cells in tuberculous and non-tuberculous tissues during M. tuberculosis infection.

Authors:  Dan Huang; Crystal Y Chen; Meihong Zhang; Liyou Qiu; Yun Shen; George Du; Keyuan Zhou; Richard Wang; Zheng W Chen
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.